Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study-Reference-Cited by-同舟云学术

Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study

Published:2023-01-18 Issue:6 Volume:72 Page:1951-1956
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Chiang Cho-Han,Chen Yuan-Jen,Chiang Cho-Hsien,Chen Cheng-Ying,Chang Yu-Cheng,Wang Shih-Syuan,See Xin Ya,Horng Chuan-Sheng,Peng Chun-Yu,Hsia Yuan Ping,Peng Cheng-Ming,Chiang Cho-Hung

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-022-03363-6.pdf

Reference27 articles.

1. Das S, Johnson DB (2019) Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer 7(1):306

2. Chiang CH, Chiang CH, Ma KS, Hsia YP, Lee YW, Wu HR et al (2022) The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations. Jpn J Clin Oncol 52(12):1389–1398

3. Dudnik E, Kareff S, Moskovitz M, Kim C, Liu SV, Lobachov A et al (2021) Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung. J Immunother Cancer 9(2):e001999

4. Correction: efficacy of immune checkpoint inhibitors for in-transit melanoma. J ImmunoTherapy Cancer. 2020;8 (2): e000440corr1

5. Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL et al (2017) Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 377(14):1345–1356

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study;Frontiers in Pharmacology;2024-07-29

2. Clinical evidence for the prognostic impact of metformin in cancer patients treated with immune checkpoint inhibitors;International Immunopharmacology;2024-06

3. Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy;Journal of Experimental & Clinical Cancer Research;2024-01-02

4. The relationship between statin administration timing and survival outcomes in patients with cancer receiving immune checkpoint blockade;Journal of Chemotherapy;2023-12-08

5. Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review;Frontiers in Immunology;2023-09-29